Biomolecules & Therapeutics : eISSN 2005-4483 / pISSN 1976-9148

Download original image
Fig. 8. Effect of galangin on phorbol ester-dependent increases in phospho-α-adducin (A) and phospho-ERK1/2 levels (B). Phospho-ERK1/2 protein levels were decreased in rapidly-frozen galangin-treated muscles in the absence of endothelium compared to vehicle-treated muscles precontracted with phorbol ester. The panel indicates average densitometric results for relative levels of phospho-ERK1/2. Data are presented as the mean of 3-5 experiments with a vertical line indicating SEM. ##p<0.01, *p<0.05, versus normal or control group respectively. Galangin: 0.1 mM galangin; PDBu: 1 μM phorbol 12,13-dibutyrate.
Biomolecules & Therapeutics 2022;30:145~150 https://doi.org/10.4062/biomolther.2021.087
© Biomolecules & Therapeutics